# Peter Sandercock

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/peter-sandercock/

## Facts

| Field | Value |
| --- | --- |
| Citations | 54,003 |
| Field | Acute Ischemic Stroke Management |
| h-index | 107 |
| i10-index | 293 |
| Last Known Institution | University College London |
| OpenAlex ID | https://openalex.org/A5029838434 |
| ORCID iD | https://orcid.org/0000-0001-8484-0135 |
| Works | 601 |

## Researcher papers

- [International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion](https://scholariq.org/papers/international-subarachnoid-aneurysm-trial-isat-of-neurosurgical-clipping-versus/)
- [Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials](https://scholariq.org/papers/effect-of-treatment-delay-age-and-stroke-severity-on-the-effects-of-intravenous/)
- [Interpretation of the evidence for the efficacy and safety of statin therapy](https://scholariq.org/papers/interpretation-of-the-evidence-for-the-efficacy-and-safety-of-statin-therapy/)
- [Stroke in China: advances and challenges in epidemiology, prevention, and management](https://scholariq.org/papers/stroke-in-china-advances-and-challenges-in-epidemiology-prevention-and/)
- [Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis](https://scholariq.org/papers/recombinant-tissue-plasminogen-activator-for-acute-ischaemic-stroke-an-updated/)
- [Comparison of treatment effects between animal experiments and clinical trials: systematic review](https://scholariq.org/papers/comparison-of-treatment-effects-between-animal-experiments-and-clinical-trials/)
- [HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment](https://scholariq.org/papers/hps2-thrive-randomized-placebo-controlled-trial-in-25-673-high-risk-patients-of/)
- [Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy](https://scholariq.org/papers/second-asymptomatic-carotid-surgery-trial-acst-2-a-randomised-comparison-of/)
- [Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial](https://scholariq.org/papers/intensive-blood-pressure-reduction-with-intravenous-thrombolysis-therapy-for/)
- [Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial](https://scholariq.org/papers/prehospital-transdermal-glyceryl-trinitrate-in-patients-with-ultra-acute/)

## Researcher topics

- [Acute Ischemic Stroke Management](https://scholariq.org/topics/acute-ischemic-stroke-management/)
- [Cerebrovascular and Carotid Artery Diseases](https://scholariq.org/topics/cerebrovascular-and-carotid-artery-diseases/)
- [Stroke Rehabilitation and Recovery](https://scholariq.org/topics/stroke-rehabilitation-and-recovery/)
- [Intracerebral and Subarachnoid Hemorrhage Research](https://scholariq.org/topics/intracerebral-and-subarachnoid-hemorrhage-research/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management-2/)

## Researcher university

- [University College London](https://scholariq.org/institutions/university-college-london/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.